Medline (MDLN) EBT Margin (2025 - 2026)
Medline's (MDLN) quarterly EBT Margin came in at 3.06% in Q2 2026, down 216.0% year-over-year from 2.64% in Q2 2025, and down 22.74% quarter-over-quarter from 3.96% in Q1 2026.
Analysis
Medline (MDLN) EBT Margin (2025 - 2026) Analysis & Trends
Medline (MDLN) has reported EBT Margin for 2 consecutive years, with 3.06% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBT Margin fell 216.0% year-over-year to 3.06% in Q2 2026; TTM through Jun 2026 was 4.28%, a N/A change from a year earlier, with the FY2025 full-year figure at 4.39%, down 50.0% from the prior year.
- EBT Margin was 3.06% for Q2 2026 at Medline, down from 3.96% in the prior quarter.
- Over five years, EBT Margin peaked at 5.21% in Q2 2025 and troughed at 3.06% in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 11.12% |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 3.06% |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 20.65% |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 5.34% |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 12.62% |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 10.05% |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | -7.32% |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 39.34% |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 3.06% |
| Mar 28, 2026 | 3.96% |
| Jun 28, 2025 | 5.21% |
| Mar 29, 2025 | 5.09% |